Cargando…
Imaging of Hsp70-positive tumors with cmHsp70.1 antibody-conjugated gold nanoparticles
Real-time imaging of small tumors is still one of the challenges in cancer diagnosis, prognosis, and monitoring of clinical outcome. Targeting novel biomarkers that are selectively expressed on a large variety of different tumors but not normal cells has the potential to improve the imaging capacity...
Autores principales: | Gehrmann, Mathias K, Kimm, Melanie A, Stangl, Stefan, Schmid, Thomas E, Noël, Peter B, Rummeny, Ernst J, Multhoff, Gabriele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572731/ https://www.ncbi.nlm.nih.gov/pubmed/26392771 http://dx.doi.org/10.2147/IJN.S87174 |
Ejemplares similares
-
In vivo imaging of CT26 mouse tumours by using cmHsp70.1 monoclonal antibody
por: Stangl, Stefan, et al.
Publicado: (2011) -
Gold Nanoparticle Mediated Multi-Modal CT Imaging of Hsp70 Membrane-Positive Tumors
por: Kimm, Melanie A., et al.
Publicado: (2020) -
Role of membrane Hsp70 in radiation sensitivity of tumor cells
por: Murakami, Naoya, et al.
Publicado: (2015) -
Hsp70 Architecture: The Formation of Novel Polymeric Structures of Hsp70.1 and Hsc70 after Proteotoxic Stress
por: Steel, Rohan, et al.
Publicado: (2012) -
Tumor Imaging and Targeting Potential of an Hsp70-Derived 14-Mer Peptide
por: Gehrmann, Mathias, et al.
Publicado: (2014)